• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Decision Support: Canadian Study Finds Issues

Article

You can give doctors decision support advice, but you can't make them take it, according to a new study in the April issue of the Journal of the American College of Radiology.

You can give doctors decision support advice, but you can't make them take it, according to a new study in the April issue of the Journal of the American College of Radiology. The study followed the implementation of decision support software system and computerized order entry at the Children's Hospital in Winnipeg. The guidelines were from the pediatric section of the Canadian Association of Radiologists (CAR).

Doctors admitting to blatantly cheating the system and ignoring advice. It's not just a matter of being head-strong, though. The study found a host of implementation issues leading to the physicians' low system acceptance.

Decision support systems have become more popular due to questions about overutilization and inappropriate imaging. The researchers noted that up to one-third of diagnostic imaging studies are thought to be partially or completely inappropriate. And there are concerns about increased radiation exposure, especially in children (see DI article on the increase of emergency room CT scans in children in the U.S. ). One way to combat this is by mandating preauthorization for high utilizers and another way is through physician education through decision support software.

During the 14 months that the decision support guidelines were studied (from July 2006 to August 2007), physicians placed 8,757 orders. Of those, only 1,678 (19.2 percent) were found to have had relevant guidelines, and 957 (10.9 percent) were inappropriate, according to those guidelines. The system suggesting cancelling the imaging order 77 percent of the time (737 cases) and changing the order to another modality in 23 percent (220 cases) for cases. The system tagged 4 percent of the total orders (367 cases) as duplicative.

Researchers found a low rate of physicians following the decision support advice - only 19 cases (2 percent) for orders considered inappropriate. As for the duplicate order advice, 11 percent of the physicians (40 of 367) cancelled their imaging as a result. Advice was followed significantly more for ultrasound than X-ray, but there was no difference for other modalities.

Researchers found a host of reasons for the low acceptance rate of decision support, ranging from implementation to software issues to the timing of the advice (doctors already made up their minds about the imaging before ordering it). Importantly, while some physicians found the decision support interesting or informative, most did not find it useful, calling it irrelevant, too generic, or a "nuisance." Some even said they were "blatantly cheating" the system by learning how to avoid boxes that gave prompts.

The researchers concluded that it's important to ensure the timing of the implementation, and also to integrate it into the existing patient information system. The lack of complete patient data and using only a subset of CAR guidelines affected the results.

Recent Videos
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, Part 1
Addressing Cybersecurity Issues in Radiology
Computed Tomography Study Shows Emergence of Silicosis in Engineered Stone Countertop Workers
Can an Emerging AI Software for DBT Help Reduce Disparities in Breast Cancer Screening?
Skeletal Muscle Loss and Dementia: What Emerging MRI Research Reveals
Magnetoencephalopathy Study Suggests Link Between Concussions and Slower Aperiodic Activity in Adolescent Football Players
Radiology Study Finds Increasing Rates of Non-Physician Practitioner Image Interpretation in Office Settings
Assessing a Landmark Change in CMS Reimbursement for Diagnostic Radiopharmaceuticals
Addressing the Early Impact of National Breast Density Notification for Mammography Reports
2 KOLs are featured in this series.
Related Content
© 2024 MJH Life Sciences

All rights reserved.